Mabwell Biotech

Overview
News
Biosimilars?
Large-molecule Therapeutics?
Product stageSegments
Early
?
Diversified Drug Developers
?

Mabwell biotech is a biopharmaceutical company based in Shanghai, China. Founded in 2017, the company focuses on developing antibody-based biotherapeutics. Mabwell operates in the biotech sector with a focus on antibody therapeutics. In August 2021, Mabwell biotech raised a significant funding round of USD 278.5 million. This substantial investment indicates strong investor interest in the company's potential and capabilities in the antibody therapeutics space.

Key customers and partnerships

The company's funding round in 2021 involved multiple investors, including Oriental Fortune Capital, Loyal Valley Capital, Shiyu Capital, Sincere Capital, and Founder H Fund. However, these are financial backers rather than customers or partners in the traditional sense.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
Shanghai CHN
Founded year:
2017
Employees:
501-1,000
IPO status:
Private
Total funding:
USD 278.5 mn
Last Funding:
USD 278.5 mn (Series A; Apr 2020)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.